Abstract
Stereotactic devices for surgical interventions on the brain were first described in 1947. Since 1987 deep brain stimulation was developed and replaced the lesional stereotactic interventions used before. Today deep brain stimulation devices have a CE- license for treatment of Parkinson's disease, tremor, dystonia, obsessive-compulsive disorders and epilepsy in Germany. Most patients with a deep brain stimulation suffer from Parkinson's disease. This articles outlines the current state of deep brain stimulation regarding indications, target point determination, intraoperative monitoring and postoperative patient care in the treatment of movement disorders.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
